Evidence map›Paper›PMID 21137088›Full record

ArticleProteomics. Clinical applications2010

Proteomic analyses of monocytes obtained from Hispanic women with HIV-associated dementia show depressed antioxidants.

Stephanie Kraft-Terry, Yamil Gerena, Valerie Wojna, Marines Plaud-Valentin, Yolanda Rodriguez, Pawel Ciborowski, Raul Mayo, Richard Skolasky, Howard E Gendelman, Loyda M Meléndez

Open access · greenAbstract read
In one paragraph

Article in Proteomics. Clinical applications, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Proteomics, biomarkers, and HIV-1: A current perspective.Proteomics. Clinical applications · 2016
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Stephanie Kraft-TerryDepartment of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Yamil Gerena
Valerie Wojna
Marines Plaud-Valentin
Yolanda Rodriguez
Pawel Ciborowski
Raul Mayo
Richard Skolasky
Howard E Gendelman
Loyda M Meléndez
University of Puerto Rico, Medical Sciences Campus · PRUniversity of Nebraska Medical Center · USJohns Hopkins University · US

Funding

Therapeutics Core (Page 286)P30MH062261 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 2000 to 2021
$37.7M
SUPPLEMENT FOR RENOVATION OF ANIMAL FACILITIES AT INSTITUTE OF NEUROBIOLOGYG12RR003051 · NCRR · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI FERNANDEZ-REPOLLET, EMMA · 1986 to 2011
$28.1M
VIRAL SHUTOFF OF HOST TRANSCRIPTION--PBCV-1 INFECTEDP20RR015635 · NCRR · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 2000 to 2009
$22.1M
Targeted Neuro Protection of HIV-1 Associated Neurologic DiseaseP01MH064570 · NIMH · UNIVERSITY OF ROCHESTER · PI GELBARD, HARRIS A · 2001 to 2014
$19.4M
Immunopathogenesis of HIV Neurological DisordersU54NS043011 · NINDS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI KRAISELBURD, EDMUNDO NELSON · 2001 to 2011
$14.6M
Neuroprotective Immunity and HIV DementiaR01NS034239 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Howard E Gendelman, R Lee Mosley · 1995 to 2026
$12.3M
Proteomics CoreP01NS043985 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI ZHENG, JIALIN CHARLES · 2003 to 2012
$11.8M
VALIDATION OF THE CLINICAL DEMENTIA RATING SCALEP20RR011126 · NCRR · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI KRAISELBURD, EDMUNDO NELSON · 1995 to 2009
$11.2M
TRANSLATIONAL PROTEOMICS CENTERG12MD007600 · NIMHD · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI FERNANDEZ-REPOLLET, EMMA · 2012 to 2016
$11.0M
Role of EAAT2 and AEG-1 in Astrocyte Dysfunction and NeurodegenerationP01NS031492 · NINDS · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI GELBARD, HARRIS A · 1993 to 2007
$10.9M
Nanomedicine and NeuroAIDSR01NS036126 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 1997 to 2017
$5.7M
Proteomic Strategies for AIDS and Drug Abuse - HIV and METH CNS SynergyP01DA026146 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 2008 to 2010
$2.9M
NCRR NIH HHS 1P20RR11126NCRR NIH HHS G12 RR003051NCRR NIH HHS G12 RR-03051NCRR NIH HHS P20 RR011126NCRR NIH HHS P20 RR015635NCRR NIH HHS P20RR15635NIDA NIH HHS 5 POI DA026146-03NIDA NIH HHS P01 DA026146NIMHD NIH HHS G12 MD007600NIMH NIH HHS 5 P30MH062261-10NIMH NIH HHS P01 MH064570NIMH NIH HHS P01 MH64570NIMH NIH HHS P30 MH062261NIMH NIH HHS R01 MH083516NINDS NIH HHS 1U54NS430NINDS NIH HHS 2R01 NS034239NINDS NIH HHS 2R37 NS36126NINDS NIH HHS 2 U54 NS43011NINDS NIH HHS 5P01 NS31492NINDS NIH HHS P01 NS031492NINDS NIH HHS P01 NS043985NINDS NIH HHS P01 NS43985NINDS NIH HHS R01 NS034239NINDS NIH HHS R01 NS036126NINDS NIH HHS R37 NS036126NINDS NIH HHS U54 NS043011NINDS NIH HHS U54NS 43011
6 · The paper itself

Abstract

purposeMonocyte ingress into the brain during progressive human immunodeficiency virus (HIV-1) infection parallels the severity of cognitive impairments. Although activated monocyte phenotypes emerge in disease, the functional correlates of these cells remain unresolved. EXPERIMENTAL

designTo this end, we studied the proteome of blood-derived monocytes obtained from Hispanic women with the most severe form of HIV-associated neurocognitive disorders, HIV-associated dementia (HAD). Monocytes isolated from peripheral blood mononuclear cells by CD14+ immunoaffinity column chromatography were >95% pure. Cells were recovered from four patients without evidence of cognitive impairment and five with HAD and analyzed by 2-D DIGE and tandem MS.

resultsImportantly, ADP ribosylhydrolase, myeloperoxidase, thioredoxin, peroxiredoxin 3, NADPH, and GTPase-activating protein were all downregulated in HAD. In regards to myeloperoxidase, thioredoxin, and peroxiredoxin 3, these changes were validated in an additional cohort of 30 patients by flow cytometry. CONCLUSIONS AND CLINICAL RELEVANCE: We conclude that deficits in monocyte antioxidants lead to neuronal damage through the loss of hydrogen peroxide scavenging capabilities; thus exposing neurons to apoptosis-inducing factors. Altered monocyte functions therefore may contribute to the development and progression of cognitive impairment.

Indexed as

Hispanic or LatinoAdultAIDS Dementia ComplexAntioxidantsChromatography, AffinityFemaleFree Radical ScavengersHumansImmunologic TechniquesMiddle AgedMonocytesPeroxidasePeroxiredoxinsProteomeThioredoxinsAntioxidantsFree Radical ScavengersPeroxidasePeroxiredoxinsProteomeThioredoxins

Identifiers

PMID21137088
PMCPMC3098323
OpenAlexW2041769972

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.